Grønning Line M, Baillie George S, Cederberg Anna, Lynch Martin J, Houslay Miles D, Enerbäck Sven, Taskén Kjetil
Biotechnology Centre of Oslo, University of Oslo, P.O. Box 1125 Blindern, 0317 Oslo, Norway.
FEBS Lett. 2006 Jul 24;580(17):4126-30. doi: 10.1016/j.febslet.2006.06.058. Epub 2006 Jun 30.
Overexpression of forkhead transcription factor FOXC2 in white adipose tissue (WAT) leads to a lean phenotype resistant to diet-induced obesity. This is due, in part, to enhanced catecholamine-induced cAMP-PKA signaling in FOXC2 transgenic mice. Here we show that rolipram treatment of adipocytes from FOXC2 transgenic mice did not increase isoproterenol-induced cAMP accumulation to the same extent as in wild type cells. Accordingly, phosphodiesterase-4 (PDE4) activity was reduced by 75% and PDE4A5 protein expression reduced by 30-50% in FOXC2 transgenic WAT compared to wild type. Thus, reduced PDE4 activity in adipocytes from FOXC2 transgenic mice contributes to amplified beta-AR induced cAMP responses observed in these cells.
白色脂肪组织(WAT)中叉头转录因子FOXC2的过表达导致对饮食诱导的肥胖具有抗性的瘦型表型。部分原因是FOXC2转基因小鼠中儿茶酚胺诱导的cAMP-PKA信号增强。在此我们表明,用咯利普兰处理FOXC2转基因小鼠的脂肪细胞,异丙肾上腺素诱导的cAMP积累增加程度不如野生型细胞。因此,与野生型相比,FOXC2转基因WAT中磷酸二酯酶4(PDE4)活性降低了75%,PDE4A5蛋白表达降低了30 - 50%。因此,FOXC2转基因小鼠脂肪细胞中PDE4活性降低有助于这些细胞中观察到的β-肾上腺素能受体(β-AR)诱导的cAMP反应放大。